Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 70,903 shares at $28.00 ($2.0M) on 2019-08-21, disclosed to the SEC on 2019-08-23.
Open-market sale of $2.0M HZNP by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 56,702 | $1.6M | 80.0% |
| 2 | $28.01 | 14,201 | $398K | 20.0% |
| Total | $28.00 avg | 70,903 | $2.0M | 100% |
| Filing → |
| HZNP | SELL | 2022-03-25 | $5.7M | — | Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2021-05-14 | $18.5M | — | Filing → |